Slow and steady wins the race: Optimizing lentiviral vector production for efficient clinical-scale manufacturing
Alexandra McCarron1,2,3
1Adelaide Medical School, The University of Adelaide, Adelaide, SA, Australia.
Molecular Therapy. Methods & Clinical Development
|September 8, 2023
Abstract
No abstract available in PubMed .


